SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Weekly Update: June 6, 2022
Black Swan Connection Newsletter Signup
Breaking News
According to Goldman Sachs they are thinking the economy is headed for a soft landing as opposed to an outright crash into a recession or worse. Pushing stocks a little higher after another down day on Friday is growing confidence that the Fed can tighten monetary policy to deal with inflation without forcing a recession. I have my doubts… Raising interest rates isn’t going to get energy prices back on track which is the major inflationary force and that isn’t going to help rising costs of labor due to labor shortages. Raising interest rates are going to make your car, mortgage and credit card charges more expensive, adding to the problem.
Joe’s kissing up to the Saudi’s for more oil production is simply a multi-billion $ transfer of wealth to the middle east and doesn’t do squat for US oil production, which is what needs to happen to solve the energy crisis.
Investing.com
— U.S. stocks are seen opening higher Monday, on growing confidence that the Federal Reserve can tighten monetary policy sufficiently to deal with soaring inflation without tipping the economy into recession.
At 7 AM ET (1100 GMT), the Dow Futures contract was up 265 points, or 0.8%, S&P 500 Futures traded 45 points, or 1.1%, higher and Nasdaq 100 Futures climbed 185 points, or 1.5%.
The main indices on Wall Street closed lower Friday, with the blue-chip Dow Jones Industrial Average ending down almost 350 points, or just over 1%, the broad-based S&P 500 1.6% lower and the tech-heavy Nasdaq Composite down 2.5%.
This followed a strong U.S. jobs report which pointed to the U.S. central bank continuing its monetary tightening policy when it meets next week.
Corporate News
Sponsored by:
The 21st Century Investment Bank Capital Raises + Strategic Advisory
Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.
Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.
For more information go to: www.DonaldCapital-NY.com
The Premier Operating System for Publicly Traded Companies
Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.
Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.
Click Here For a Sequire Power Point Presentation
To schedule a demo email me at cdilley@smm.global or call 727-459-7378
6-6-2022 SRAX (NASDAQ: SRAX)
SRAX Reports Record Full Year and Q4 2021 Financial Results
LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is providing full year financial results.
SRAX exceeded guidance of $31.5M for 2021, with SRAX totaling $28.6 million in revenue, and its former subsidiary, BIGtoken, totaling $3.4 million in revenue. Due to the deconsolidation of BIGtoken as of December 31, 2021, the following full year earnings report includes BIGtoken’s results from operations as discontinued operations. Due to an increase in bookings, SRAX is providing guidance of $47M-$50M for 2022.
5-31- 2022 Ecrid, Inc (OTC ECDD)
ECRID/ResMac Mortgage Strikes Deal That Can Change the Entire Credit Industry
PALM BEACH, FL , May 31, 2022 /PRNewswire/ — ECRID, Inc. (Stock Symbol: ECDD) and ResMac Mortgage have teamed up to help millions of Americans become home owners who have difficulty obtaining mortgages or refinancing existing mortgages in this current economic climate. ECRID, the new Credit Bureau offers the tools and resources to assist Americans in taking control of their financial destinies to become financially stable and build wealth. Through the ECRID platform www.ecrid.com customers can sign up and create their own ECRID Credit Report and Apply for a Mortgage through ECRID Lending Corp. and begin their journey to financial health.
5-31-2022 SRAX (NASDAQ: SRAX)
SRAX to host Full year Earnings conference call June 6th , 2022
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will announce Q4 and Full Year earnings for 2021 this Monday, June 6th, 2022.
Conference Call:
SRAX’s Founder and CEO Christopher Miglino, and CFO Michael Malone will provide an operational and financial summary for Full Year 2021 on a video call, with a live question and answer session, on Monday, June 6th, at 10:30 am ET / 7:30 am PT.
To register for the live webcast and view the presentation, please sign up here: https://audience.mysequire.com/webinar-view?webinar_id=b431d84a-22ca-475f-bd11-be0df096edb0
To access the conference by phone:
Dial in: +1 346-248-7799
Meeting ID: 92139622922
Passcode: 432792
SRAX was previously delayed from filing its 10-K due to accounting matters related to its former subsidiary. These matters have since been resolved and the company will proceed with filing the 10-K this upcoming week.
Welcome a new player in the beverage industry !!
I just got my first samples of DINO last week and it is outstanding
4-12-2022 International Food and Beverage (OTC IFBC)
Plainview, New York–(Newsfile Corp. – April 12, 2022) – Italian Food & Beverage Corp. (OTC PINK: IFBC) last year revenue closed with a solid 30% sales increase compared to the previous year, the Company in the first quarter of this year has launched its Energy Drink in Italy through its recently acquired European Division, located by the Capital in the Region of Lazio.
The Company has garnered 2 new corporate executives. Chief Marketing Officer Chris Pati – 30+ year iconic Music Business Veteran and Founder/Chairman of IndiMusic TV, Entrepreneur and media visionary. New President Alan Cohen, is an entrepreneur with expertise on building businesses and establishing possibilities on increasing sales as well as an expert in marketing and various sports venues.
Italian Launch
With the acquisition purposes, we will be able to promote the sale of the IFBC’s Energy Drink throughout Italy, with the eventual expansion into all the countries of Europe. The Dino Luzzi Energy Drink has gained traction in Italy and is on its way to international recognition. This is evidenced by the increased allocations of shelf space by foreign and domestic retailers.
Check out this video!!
Plainview, New York–(Newsfile Corp. – April 12, 2022) – Italian Food & Beverage Corp. (OTC PINK: IFBC) last year revenue closed with a solid 30% sales increase compared to the previous year, the Company in the first quarter of this year has launched its Energy Drink in Italy through its recently acquired European Division, located by the Capital in the Region of Lazio.
The Company has garnered 2 new corporate executives. Chief Marketing Officer Chris Pati – 30+ year iconic Music Business Veteran and Founder/Chairman of IndiMusic TV, Entrepreneur and media visionary. New President Alan Cohen, is an entrepreneur with expertise on building businesses and establishing possibilities on increasing sales as well as an expert in marketing and various sports venues.
Italy 2022 Windsurfer Spring Cup
On April 9th and 10th of this year, this new Division sponsored the Windsurfer Spring Cup National Regatta, the venue for which is historic Anzio, Italy. Throughout this Regatta, the Energy Drink was promoted extensively, in particular, on the beach of Anzio with young, lively, attractive company representatives presenting the product as it is, and in a new line of specifically formulated cocktails.
This promotional effort was further enhanced by way of a festival-like atmosphere, which was generated by the presence of many great food stands, restaurants, shops, children’s and family entertainment venues at a nearby shopping center. At the center of it all, and resting atop a specially constructed cupola, was a 3-meter tall, brightly illuminated Dino Luzzi Energy Drink, which was clearly visible to tourists and locals alike, from the Ciampino Rome airport, and will remain accessible to the local community for the entire summer.
Read the Complete Press Release
05-18-2021 CanB Corp (OTC CANB)
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY, May 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company’s financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
- Revenue increased 606% to $1.9 million
- Gross profit increased 291% to $0.7 million
- Adjusted EBITDA loss decreased 30% to $0.9 million
- Total assets increased to $17.0 million
- Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
- Solidified and integrated vertical processing capabilities from recent acquisitions
- Advanced build-out of first CBD lounge in Miami, Florida
- Continuing path for potential NASDAQ up-listing
5-17-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
WEXFORD, Pa., May 17, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Terms of the deal were not disclosed.
The exclusive option agreement involves the intellectual property rights to three technologies jointly developed in the laboratories of Jason Lohmueller, Ph.D., Assistant Professor of Immunology; Alexander Deiters, Ph.D., Professor of Chemistry; and Olivera Finn, Ph.D., Professor of Immunology: 1) mSA2 affinity-enhanced biotin-binding CAR, 2) universal self-labeling SynNotch and CARs for programable antigen-targeting, and 3) conditional control of universal CAR-T cells through stimulus-reactive adaptors. Per the option agreement, Coeptis paid the University of Pittsburgh a non-refundable fee for the exclusive option to license the patent rights to each of the three technologies. Coeptis has until October 29, 2022, to exercise the options and pay the specified exercise considerations. The option agreement may be extended an additional six months, subject to the agreement of both parties.
5-10-2022 SRAX (NASDAQ: SRAX)
NSAV Announces Partnership with SRAX to Enhance Investor Communications
London, England, May 10, 2022 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced that they have entered into a partnership with SRAX (NASDAQ: SRAX) to maximize and accelerate its communications for interested investors, shareholders, and supporters.
Through SRAX, a publicly traded company offering premier operating system tools for publicly traded companies, NSAV will have the ability to further reach its community through sophisticated solutions to assist it in maintaining, communicating, and expanding its shareholder base.
5-2-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF)
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary
– $6.5 million all-cash transaction, including milestone payments
– Enables exclusive focus on drug pipeline
TORONTO, May 02, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian full-service distributor of pharmaceuticals and medical devices to dental professionals.
4-19-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
Transaction expected to accelerate Coeptis’ ability to progress its innovative cell therapy platforms for cancer
David Mehalick of Coeptis to serve as Chief Executive Officer;
Chris Calise of Bull Horn to join the Board of Directors
Merger anticipated to close in third quarter 2022; combined company anticipated to list on Nasdaq
WEXFORD, Pa., and MIAMI, Fla., April 19, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, and Bull Horn Holdings Corp. (Nasdaq: BHSE) (“Bull Horn”), a special purpose acquisition company (SPAC), today announced they have entered into a definitive merger agreement for a business combination that will result in Coeptis becoming a wholly-owned subsidiary of Bull Horn. Under the terms of the merger agreement, a wholly-owned subsidiary of Bull Horn will merge with and into Coeptis and the holders of the outstanding Coeptis shares will receive equity in Bull Horn valued at $175 million (subject to adjustments).
04-13-2022 Coeptis Therapeutics, Inc. OTC COEP
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to enter into a strategic agreement with Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, to sell Statera’s rights to Entolimod and other related toll-like receptor 5 (TLR5) agonists. The consummation of the transaction is contingent upon negotiation of a definitive agreement and satisfaction of a number of closing conditions, including a contingency on Coeptis financing.
3-30-2022 SRAX (NASDAQ: SRAX)
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
LD Micro is host to the most influential conferences in the small and microcap world. Chris Lahiji, founder of the prestigious function, notes the success of the Main Event last October as a “great success that restored humanity within our industry. People could finally see each other and connect again in person. As a result, the upcoming Invitational was the fastest sell-out in our history.”
Alternative Investments
Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama
3700 Acre Private Island in the Las Perlas Islands
7.4 Acre beachfront paradise for development or private retreat
Message me on Linkedin and check our latest commercial listings:
https://www.linkedin.com/in/carldilley/
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
Black Swan Connection Newsletter Signup
| June 6, 2022 COMPANY QUOTES, LISTINGS RESEARCH AND NEWS Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD) Profile Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News Can B Corp (CANB) Profile News Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News Social Reality, Inc. (SRAX) Profile News International Food and Beverage Profile |
May 18, 2022
ValuEngine Weekly Report
The Many Faces of QQQ
May 31, 2022 by Herb Blank
The history of QQQ, Invesco QQQ Trust, is that it was a game-changer from the very start. Beginning in 1999 with the development of the Nasdaq-100 index by John Jacobs, then a Nasdaq executive and now a professor at Georgetown and Steven Bloom, the product was an overnight success.
It was Jacobs’ vision to take advantage of the Nasdaq’s success of getting innovative tech companies to list there just as dial-up internet was in its early stages of adoption by the public. At the time, Nasdaq’s catch phrase was “the Stock Market for the Next 100 years”. The index leadership certainly captured that spirit. Between effective advertising and outrageously high returns in 1999, QQQ captured the imagination of brokers and financial advisors and beyond that even saw meaningful flows from the retail market. This was unprecedented at the time for the ETF industry. Even though the SPDR (SPY) had launched in 1993 and a handful of other products followed, SPY, MDY, DIA and 17 country ETFs called WEBS (now iShares-MSCI) were primarily institutional trading products used mainly as proxies for futures. Success had been measured more by trading volume than asset capture. QQQ changed all that and paved the way for an avalanche of new products launched in the next 5 years, including iShares and Select Sector SPDRs.
Read Complete Report
ValuEngine new strategies, Podcast introduction
ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.
VIEW JORDAN’S INTRODUCTORY PODCAST HERE
on www.ValuEngine.com
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE
Black Swan Research Coverage and Subscription Service
Click Here>>
Event Calendar Updates
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
For more information on LD Micro, visit ldmicro.com.
Rocky Mountain Microcap Conference IX.
The conference was a good success with great attendance and a recap will be available soon.
dave@trickleresearch.com
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
Distribution (Reach)
SMM Global Twitter Acct (Impressions last 30 days) 520
SMM Global Facebook Page (Reach last-30 days) 6,462
SMM Linkedin Pages (contacts) 1,100
SMM Youtube Channel (followers) 6
SMM Instagram Page * (followers) 11
Direct Email * 220,000
Total 256,460